ChemicalBook >> CAS DataBase List >>nimotuzumab

nimotuzumab

CAS No.
828933-51-3
Chemical Name:
nimotuzumab
Synonyms
nimotuzumab;Research Grade Nimotuzumab(DHB86914)
CBNumber:
CB42498825
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file

nimotuzumab Properties

NCI Dictionary of Cancer Terms nimotuzumab
FDA UNII 6NS400BXKH
NCI Drug Dictionary nimotuzumab

nimotuzumab price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Biosynth Carbosynth BN165591 Nimotuzumab 828933-51-3 1mg $600 2021-12-16 Buy
Product number Packaging Price Buy
BN165591 1mg $600 Buy

nimotuzumab Chemical Properties,Uses,Production

Description

Overexpression of epidermal growth factor receptor (EGFR), a transmembrane receptor tyrosine kinase, is prevalent in malignant tumors of epithelial origin and is especially common in breast, head and neck, colon, and lung cancer. With EGFR overexpression, prognosis is poor due to associated tumor invasion, metastasis, enhanced angiogenesis, and resistance to chemotherapy; thus, modulation of EGFR-mediated signaling is an attractive target for intervention. Small-molecule kinase inhibitors (gefitinib and erlotinib) and a monoclonal antibody (cetuximab) specific for EGFR are in clinical evaluation, but treatment cessation due to development of severe acne-like rash is common with these EGFR antagonists. Notably, nimotuzumab, a humanized form of the murine IgG2a monoclonal antibody that has been launched in India for treatment of head and neck cancers overexpressing EGFR, demonstrates clinical efficacy devoid of the rash toxicity. .

Originator

Center for Molecular Immunology (Cuba)

brand name

BioMab EFGR, Theraloc

nimotuzumab Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 14)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354 support@targetmol.com United States 19973 58
LGM Pharma 1-(800)-881-8210 inquiries@lgmpharma.com United States 2127 70
NCE Biomedical Co.,Ltd. 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 China 1494 55
SPIRO PHARMA eric_feng1954@126.com China 9254 55
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 info@efebio.com China 9709 58
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994 2853530910@QQ.com China 8012 62
Wuhan Chemstan Biotechnology Co., Ltd. 15926423062 422450190@qq.com China 10132 58
Abmole Bioscience Inc. 021-50967598 02150967598 sales@abmole.cn China 4495 58
Jiangxi ravel Biotechnology Co.,Ltd 13184580281 hj@ruiweier.cn China 2102 58
Hubei Kele Fine Chemical Co., Ltd 027-59101668 19945030958 2881924765@qq.com China 7977 58
nimotuzumab Research Grade Nimotuzumab(DHB86914) 828933-51-3 828933-61-3